BackOlema Pharmaceuticals Overview

Olema Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for OLMA.

Quarterly Other Income/Expense

$4.90M
↑ 9.21% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

$16.66M
↑ 19.86% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin